Is there a role for immunotherapy in HER2-positive breast cancer?

Although the prognosis and prediction of therapeutic benefit for breast cancer patients overexpressing the human epidermal growth factor receptor 2 (HER2) have dramatically changed with the administration of anti-HER2-targeted therapies, HER2-positive metastatic breast cancer is still an incurable d...

Descripción completa

Detalles Bibliográficos
Autores principales: Holgado, Esther, Perez-Garcia, Jose, Gion, Maria, Cortes, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093898/
https://www.ncbi.nlm.nih.gov/pubmed/30131972
http://dx.doi.org/10.1038/s41523-018-0072-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093898/
https://www.ncbi.nlm.nih.gov/pubmed/30131972
http://dx.doi.org/10.1038/s41523-018-0072-8

Ejemplares similares